Home>News & Events>Press Releases>TRxA

News & Events

  • June 28, 2023

    C-Path’s TRxA Announces $750,000 in Research Awards to Accelerate its First Drug Development Projects

     TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic scientists in advancing novel compounds through the drug development process. Launched in June 2022, TRxA is a global drug discovery and development program focused on supporting academic scientists in defining optimal strategies......
  • June 9, 2022

    C-Path Launches Unique Translational Therapeutics Accelerator with Support from Cottrell Foundation

     The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 — Critical Path Institute (C-Path) today announced it has been awarded a grant from the Frederick Gardner Cottrell Foundation, a non-profit organization established by Research Corporation Technologies, Inc. (RCT) that provides financial support for scientific research and educational programs,......
Refine:

Period

Program

  • All Programs
  • CPAD - Critical Path For Alzheimer's Disease
  • TTC - Transplant Therapeutics Consortium
  • T1D - Type 1 Diabetes Consortium
  • HD-RSC - Huntington’s Disease Regulatory Science Consortium
  • RDCA-DAP - Rare Disease Cures Accelerator-Data and Analytics Platform
  • TOMI-T1D - Trial Outcome Markers Initiative in T1D
  • QuantMed - Quantitative Medicine Program
  • PredicTox KE - PredicTox Knowledge Environment
  • CDRC - CURE Drug Repurposing Collaboratory
  • SHIP-MD - System of Hospitals for Innovation in Pediatrics – Medical Devices
  • CPTA - Critical Path to Therapeutics for the Ataxias
  • CP-SCD - Critical Path for Sickle Cell Disease
  • RD-COA Consortium - Rare Disease Clinical Outcome Assessment Consortium
  • TRxA - Translational Therapeutics Accelerator
  • CP-RND - Critical Path for Rare Neurodegenerative Diseases
  • CPA-1 - Critical Path for Alpha-1 Antitrypsin Deficiency
  • CFAST - Coalition For Accelerating Standards and Therapies
  • BmDR - Biomarker Data Repository
  • CPP - Critical Path for Parkinson's
  • CPTR - Critical Path to TB Drug Regimens
  • DCC - Data Collaboration Center
  • D-RSC - Duchenne Regulatory Science Consortium
  • INC - International Neonatal Consortium
  • MSOAC - Multiple Sclerosis Outcome Assessments Consortium
  • PKD - Polycystic Kidney Disease Outcomes Consortium
  • PRO Consortium - Patient-Reported Outcome Consortium
  • eCOA Consortium - Electronic Clinical Outcome Assessment Consortium
  • PSTC - Predictive Safety Testing Consortium
  • PTC - Pediatric Trials Consortium
  • TB-PACTS - TB-Platform for Aggregation of Clinical TB Studies

Category

Tags

x